Clinical Trials Directory

Trials / Completed

CompletedNCT07022158

Antenatal Body Shape Index and Pregnancy Complications

Relationship Between Antenatal Body Shape Index and Pregnancy Complications

Status
Completed
Phase
Study type
Observational
Enrollment
170 (actual)
Sponsor
Abant Izzet Baysal University · Academic / Other
Sex
Female
Age
18 Years – 43 Years
Healthy volunteers
Accepted

Summary

Background/aim: Gestational diabetes (GDM), gestational hypertension (GHT) and preeclampsia are common complications of pregnancy. In this study, it was aimed to determine the relationship between body shape index (ABSI), calculated based on antenatal measurements of the height, weight and waist circumference, and GDM, GHT and preeclampsia. Materials and methods: 170 patients at 6-16th weeks of gestation were prospectively analyzed. Body mass index (BMI) and ABSI were calculated. Patients were analyzed according to the presence of GDM, GHT and preeclampsia at follow-up. Our study is the first in terms of its subject and makes a significant contribution to the literature.

Conditions

Interventions

TypeNameDescription
OTHERThe patients participating in the study were between 6 and 16 weeks of pregnancy. Height, body weight, and waist circumference were measured at the first antenatal visit at 2 weeks.170 patients at 6-16th weeks of gestation were prospectively analyzed. Body mass index (BMI) and ABSI were calculated. Patients were analyzed according to the presence of GDM, GHT and preeclampsia at follow-up.

Timeline

Start date
2023-09-01
Primary completion
2024-03-01
Completion
2024-04-01
First posted
2025-06-15
Last updated
2025-06-15

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07022158. Inclusion in this directory is not an endorsement.